Northwire Canada EditionSunday, July 12, 2026
Northwire
GLDN 0.055 +0.0% BRON 0.040 +0.0% BTO 5.43 −0.7% ESK 0.365 −2.7% AUMN 0.275 +0.0% GGX 0.040 +0.0% S 0.155 +29.2% NNX 0.035 +0.0% ABX 51.90 −0.6% TTS 2.40 −4.0% FCI 0.400 −9.1% GR 0.075 +0.0% AII 23.38 +12.4% TUNG 1.72 +1.8% LGO 1.01 −2.9% EMM 0.080 +0.0% GLDN 0.055 +0.0% BRON 0.040 +0.0% BTO 5.43 −0.7% ESK 0.365 −2.7% AUMN 0.275 +0.0% GGX 0.040 +0.0% S 0.155 +29.2% NNX 0.035 +0.0% ABX 51.90 −0.6% TTS 2.40 −4.0% FCI 0.400 −9.1% GR 0.075 +0.0% AII 23.38 +12.4% TUNG 1.72 +1.8% LGO 1.01 −2.9% EMM 0.080 +0.0%
None

SEDAR Interim Financial Statements

OPTI · Price
[
  {
    "companyName": "Optimi Health Corp.",
    "reportingPeriodEnd": "2025-12-31",
    "reportStatus": "Unaudited",
    "auditorName": null,
    "auditorKeyMatters": [],
    "balanceSheet": {
      "cashAndCashEquivalents": 491750,
      "accountsReceivable": 118852,
      "inventory": 310388,
      "prepaidsAndAdvances": 190116,
      "totalCurrentAssets": 1111106,
      "deposits": 17548,
      "deferredFinancingCosts": 807936,
      "plantAndEquipment": 12128382,
      "rightOfUseAssets": 171231,
      "totalAssets": 14236203,
      "accountsPayableAndAccruedLiabilities": 1549202,
      "dueToRelatedParties": 917869,
      "deferredRevenue": 207759,
      "currentPortionOfLeaseLiabilities": 27426,
      "currentPortionOfLoansPayable": 2916000,
      "convertibleDebentures": 3450000,
      "totalCurrentLiabilities": 9068256,
      "leaseLiability": 150934,
      "totalLiabilities": 9219190,
      "shareCapital": 31691943,
      "reserves": 1636858,
      "accumulatedDeficit": -28311788,
      "totalShareholdersEquity": 5017013,
      "totalLiabilitiesAndShareholdersEquity": 14236203,
      "cashPerShare": 0.0051,
      "workingCapitalPerShare": -0.0410
    },
    "incomeStatement": {
      "revenue": 0,
      "costOfSales": 0,
      "grossMargin": 0,
      "advertisingPromotionAndPublicRelations": 1949,
      "amortizationAndDepreciation": 264749,
      "bankChargesAndInterest": 278791,
      "consulting": 279193,
      "consumablesSuppliesAndOverhead": 39016,
      "insurance": 56592,
      "investorRelations": 184670,
      "officeRentAndAdministration": 32313,
      "professionalFees": 30671,
      "researchAndDevelopment": 48495,
      "shareBasedCompensation": 327,
      "shipping": 7629,
      "transferAgentAndFilingFees": 59471,
      "travelAndAccommodation": 11435,
      "wagesAndBenefits": 264087,
      "totalExpenses": 1559388,
      "interestAndOtherIncome": 5413,
      "lossAndComprehensiveLossForThePeriod": 1553975,
      "lossPerShareBasicAndDiluted": -0.02,
      "weightedAverageNumberOfCommonSharesOutstandingBasicAndDiluted": 96638169
    },
    "cashFlowStatement": {
      "netLossForTheYear": -1553975,
      "amortizationAndDepreciation": 264749,
      "shareBasedCompensation": 327,
      "loanAccretion": 31500,
      "leaseInterest": 6841,
      "changesInAccountsReceivable": -23798,
      "changesInInventory": 0,
      "changesInDeferredRevenue": 0,
      "changesInPrepaidsAndAdvances": 85604,
      "changesInDueToRelatedParty": 393543,
      "changesInAccountsPayableAndAccruedLiabilities": 158222,
      "cashUsedInOperatingActivities": -636987,
      "plantAndEquipmentExpenditures": -3428,
      "cashUsedInInvestingActivities": -3428,
      "subscriptionsReceivedInAdvance": 0,
      "shareIssueCosts": 0,
      "paymentOfLeaseObligations": -12900,
      "cashProvidedByFinancingActivities": -12900,
      "changeInCashAndCashEquivalentsDuringThePeriod": -653315,
      "cashAndCashEquivalentsBeginningOfPeriod": 1145065,
      "cashAndCashEquivalentsEndOfPeriod": 491750
    },
    "investmentsAndOtherAssets": [
      {
        "type": "Subsidiary",
        "description": "Optimi Labs Inc.",
        "ownershipPercentage": 100,
        "value": null,
        "notes": "100% ownership interest"
      },
      {
        "type": "Subsidiary",
        "description": "Optimi Nutraceuticals Corp.",
        "ownershipPercentage": 100,
        "value": null,
        "notes": "100% ownership interest"
      },
      {
        "type": "Term Deposit",
        "description": "Term deposit – prime – 2% Demand",
        "ownershipPercentage": null,
        "value": 5000,
        "notes": "Cash equivalent"
      }
    ],
    "shareStructure": {
      "authorizedShares": "Unlimited",
      "issuedShares": 96638169,
      "classesOfShares": ["Common shares without par value"],
      "warrants": [
        {
          "number": 100000,
          "exercisePrice": 0.5,
          "expiryDate": "2026-08-04"
        },
        {
          "number": 100000,
          "exercisePrice": 0.5,
          "expiryDate": "2026-08-29"
        },
        {
          "number": 100000,
          "exercisePrice": 0.5,
          "expiryDate": "2026-11-01"
        },
        {
          "number": 758350,
          "exercisePrice": 0.4,
          "expiryDate": "2026-02-23"
        },
        {
          "number": 333334,
          "exercisePrice": 0.4,
          "expiryDate": "2026-05-10"
        },
        {
          "number": 908316,
          "exercisePrice": 0.4,
          "expiryDate": "2026-05-29"
        },
        {
          "number": 898333,
          "exercisePrice": 0.4,
          "expiryDate": "2026-08-15"
        },
        {
          "number": 658334,
          "exercisePrice": 0.4,
          "expiryDate": "2027-01-24"
        },
        {
          "number": 400000,
          "exercisePrice": 0.25,
          "expiryDate": "2027-07-17"
        }
      ],
      "options": [
        {
          "number": 40000,
          "exercisePrice": 0.6,
          "expiryDate": "2026-01-26"
        },
        {
          "number": 1925000,
          "exercisePrice": 1.5,
          "expiryDate": "2026-05-06"
        },
        {
          "number": 50000,
          "exercisePrice": 1.5,
          "expiryDate": "2026-01-31"
        },
        {
          "number": 10000,
          "exercisePrice": 0.65,
          "expiryDate": "2028-03-29"
        },
        {
          "number": 100000,
          "exercisePrice": 0.65,
          "expiryDate": "2028-04-26"
        },
        {
          "number": 100000,
          "exercisePrice": 0.65,
          "expiryDate": "2028-11-01"
        },
        {
          "number": 15000,
          "exercisePrice": 0.35,
          "expiryDate": "2026-01-31"
        },
        {
          "number": 700000,
          "exercisePrice": 0.165,
          "expiryDate": "2028-08-20"
        },
        {
          "number": 600000,
          "exercisePrice": 0.2,
          "expiryDate": "2028-08-20"
        },
        {
          "number": 600000,
          "exercisePrice": 0.3,
          "expiryDate": "2028-08-20"
        }
      ],
      "rightsConvertibleInstruments": "Convertible debentures convertible at $0.15 per share"
    },
    "managementCompensation": {
      "currency": "CAD",
      "periods": {
        "periodEndedDecember312025": {
          "consultingFees": 142645
        },
        "periodEndedDecember312024": {
          "consultingFees": 161234
        }
      },
      "namedIndividuals": [],
      "otherRelatedPartyTransactions": [
        {
          "counterparty": "BC Green Pharmaceuticals Inc.",
          "description": "Lease agreement for industrial land (Princeton Facilities)",
          "amount": 4300,
          "period": "Monthly"
        },
        {
          "counterparty": "Company controlled by a director",
          "description": "Loan principal",
          "amount": 1000000,
          "period": "Outstanding as of Dec 31, 2025"
        },
        {
          "counterparty": "Two companies controlled by directors",
          "description": "Convertible debenture principal",
          "amount": 3450000,
          "period": "Outstanding as of Dec 31, 2025"
        }
      ]
    },
    "subsequentEvents": [
      {
        "eventDate": null,
        "description": "105,000 stock options expired unexercised",
        "impactValue": null
      },
      {
        "eventDate": null,
        "description": "Granted 850,000 stock options with an exercise price of $0.50 and a term of 5 years. These options vest one quarter on the grant date and one quarter every year thereafter.",
        "impactValue": null
      },
      {
        "eventDate": null,
        "description": "Granted 555,000 restricted share rights that vest one quarter on the grant date and one quarter every year thereafter.",
        "impactValue": null
      },
      {
        "eventDate": null,
        "description": "In the process of completing an initial public offering of its common shares on the Nasdaq Capital Market under the symbol “OPTH”.",
        "impactValue": null
      }
    ]
  }
]
Read the original news release →

More from Optimi Health Corp